Novartis AG is 153.7x more valuable than Trevi Therapeutics, Inc. by market capitalization ($293.70 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TRVI | NVS |
|---|---|---|
| Market cap | $1.91 B | $293.70 B |
| US-listed rank | #2139 | #46 |
| Net income (latest FY) | -$42.76M | - |
| SEC filings | 524 | 947 |
Novartis AG is 153.7x more valuable than Trevi Therapeutics, Inc. by market capitalization ($293.70 B vs $1.91 B).
Full pages: Trevi Therapeutics, Inc. and Novartis AG, or browse the full rankings.